Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Transfusion
|
March 12, 2021
Platelet transfusion refractoriness and anti-HLA immunization
Lucie Blandin, Aurore Dougé, Amandine Fayard, et al.
Bulletin Du Cancer
|
April 12, 2023
[Second allogeneic (update). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]
Nabil Yafour, Marie-Anne Couturier, Cécile Borel, et al.
Bulletin Du Cancer
|
October 28, 2022
[Graft failure, poor graft function erythroblastopenia: Actualization of definitions, diagnosis and treatment: Guidelines from the SFGM-TC]
Micha Srour, Amandine Fayard, Federica Giannotti, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 19, 2017
Expression of embryonic stem cell markers in acute myeloid leukemia
Tiphanie Picot, Carmen Mariana Aanei, Amandine Fayard, et al.
Bulletin Du Cancer
|
March 8, 2021
[Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CAR T cells): Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]
Tamim Alsuliman, Laurianne Drieu La Rochelle, Arnaud Campidelli, et al.
Haematologica
|
April 9, 2026
Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA study
Axel André, Estelle Bourbon, Guillaume Cartron, et al.
Blood Advances
|
September 30, 2025
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group
Marion Aymard, Morgane Cheminant, Roch Houot, et al.
Bone Marrow Transplantation
|
February 17, 2019
Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)
Amandine Fayard, Elisabeth Daguenet, Didier Blaise, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 10, 2022
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study
Baptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, et al.
Bone Marrow Transplantation
|
August 31, 2023
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC
Gaëlle Rey, Elisabeth Daguenet, Paul Bonjean, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Transfusion
|
March 12, 2021
Platelet transfusion refractoriness and anti-HLA immunization
Lucie Blandin, Aurore Dougé, Amandine Fayard, et al.
Bulletin Du Cancer
|
April 12, 2023
[Second allogeneic (update). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]
Nabil Yafour, Marie-Anne Couturier, Cécile Borel, et al.
Bulletin Du Cancer
|
October 28, 2022
[Graft failure, poor graft function erythroblastopenia: Actualization of definitions, diagnosis and treatment: Guidelines from the SFGM-TC]
Micha Srour, Amandine Fayard, Federica Giannotti, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 19, 2017
Expression of embryonic stem cell markers in acute myeloid leukemia
Tiphanie Picot, Carmen Mariana Aanei, Amandine Fayard, et al.
Bulletin Du Cancer
|
March 8, 2021
[Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CAR T cells): Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]
Tamim Alsuliman, Laurianne Drieu La Rochelle, Arnaud Campidelli, et al.
Haematologica
|
April 9, 2026
Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA study
Axel André, Estelle Bourbon, Guillaume Cartron, et al.
Blood Advances
|
September 30, 2025
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group
Marion Aymard, Morgane Cheminant, Roch Houot, et al.
Bone Marrow Transplantation
|
February 17, 2019
Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)
Amandine Fayard, Elisabeth Daguenet, Didier Blaise, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 10, 2022
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study
Baptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, et al.
Bone Marrow Transplantation
|
August 31, 2023
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC
Gaëlle Rey, Elisabeth Daguenet, Paul Bonjean, et al.
Page
of 1